The insider sales are modest relative to market cap and not inherently bearish, but the involvement of a major 10% owner (Gilde) selling ~$464K warrants attention. Monitor for any subsequent Form 144 filings or a potential secondary offering, which the cross-filing actuarial verdicts flag as an amplified combination.
Price Chart
Executive Summary
Two insiders at Shoulder Innovations sold a total of ~$498K in shares over a 7-day window, led by 10% owner Gilde Healthcare (~$464K) and the COO (~$34K). The sales represent ~0.11% of the $459M market cap, falling at the low end of the 'modest' proportionality band. While insider sales are generally weak predictors, the cluster is amplified by the presence of a large 10% owner seller and the company's strong recent stock performance, warranting monitoring for further insider activity or a potential secondary offering.
Key Financial Metrics
Key Facts
- Two insiders sold shares totaling ~$498K in the past week.
- Gilde Healthcare Holding B.V., a 10% owner, sold ~$464K worth of shares.
- COO Matthew Fraser sold ~$34K worth of shares.
- Total sales represent ~0.11% of the $459M market cap.
- The cluster is amplified by cross-filing context (cluster-insider-trades + cluster-offering-context).
Financial Impact
~$498K in insider sales, representing 0.11% of market cap.
Risk Factors
- Insider selling could accelerate, signaling a potential top or upcoming secondary.
- The 10% owner's sale may indicate reduced conviction or a need for liquidity.
- The stock's recent strong performance could lead to profit-taking.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-SI-1787614638629 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 15, 2026 12d ago | Press Release | $18.09 | awaiting T+60 | — | $19.34 (+6.91%) |
Oct 8, 2026 19d ago | 8-K | $17.89 | awaiting T+60 | — | $19.34 (+8.11%) |
Aug 24, 2026 9w ago | Insider Cluster | $22.32 | awaiting T+60 | — | $19.34 (−13.35%) |
Aug 14, 2026 10w ago | EFFECT | $20.73 | awaiting T+60 | — | $19.34 (−6.71%) |
Aug 10, 2026 11w ago | 8-K | $20.75 | awaiting T+60 | — | $19.34 (−6.80%) |
Jul 29, 2026 12w ago | 144 | $23.72 $19.75 | ▲ +16.74% | ▲ +21.47% | $19.34 (+18.47%) |
Jun 29, 2026 17w ago | 8-K | $21.09 $17.61 | ▼ −16.50% | ▼ −20.89% | $19.34 (−8.30%) |
May 13, 2026 23w ago | 8-K | $15.59 $20.75 | ▲ +33.10% | ▲ +29.51% | $19.34 (+24.05%) |
Apr 29, 2026 25w ago | DEFA14A | $12.28 $20.41 | ▲ +66.21% | ▲ +62.09% | $19.34 (+57.49%) |
Apr 27, 2026 26w ago | 8-K | $13.53 $20.31 | ▲ +50.11% | ▲ +45.33% | $19.34 (+42.94%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers